Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1213 ARTÍCULOS , VIENDO DEL 751 AL 765

Florbetapir F 18 amyloid PET and 36-month cognitive decline: a prospective multicenter study

Doraiswamy PM, Sperling RA, Johnson K, Reiman EM, Wong TZ, Sabbagh MN, Sadowsky CH, Fleisher AS, Carpenter A, Joshi AD, Lu M, Grundman M, Mintun MA, Skovronsky DM, Pontecorvo MJ; AV45-A11 Study Group; AV45-A11 Study Group.

Mol Psychiatry. 2014 Sep;19(9):1044-51. doi: 10.1038/mp.2014.9. Epub 2014 Mar 11.

Association of brain amyloid-β with cerebral perfusion and structure in Alzheimer's disease and mild cognitive impairment

Mattsson N, Tosun D, Insel PS, Simonson A, Jack CR Jr, Beckett LA, Donohue M, Jagust W, Schuff N, Weiner MW; Alzheimer's Disease Neuroimaging Initiative.

Brain. 2014 May;137(Pt 5):1550-61. doi: 10.1093/brain/awu043. Epub 2014 Mar 12.

Postural sway, falls, and cognitive status: a cross-sectional study among older adults

Mignardot JB, Beauchet O, Annweiler C, Cornu C, Deschamps T.

J Alzheimers Dis. 2014;41(2):431-9. doi: 10.3233/JAD-132657.

[Awareness disorders in Alzheimer's disease and in mild cognitive impairment]

Jacus JP, Dupont MP, Herades Y, Pelix C, Large H, Baud M.

Encephale. 2014 Apr;40(2):180-7. doi: 10.1016/j.encep.2013.10.003. Epub 2014 Mar 11.

Apolipoprotein E gene polymorphism and Alzheimer's disease in Chinese population: a meta-analysis

Liu M, Bian C, Zhang J, Wen F.

Sci Rep. 2014 Mar 17;4:4383. doi: 10.1038/srep04383.

Possible role of vascular risk factors in Alzheimer's disease and vascular dementia

Hasnain M, Vieweg WV.

Curr Pharm Des. 2014;20(38):6007-13. doi: 10.2174/1381612820666140314153440.

Effect of physical activity on memory function in older adults with mild Alzheimer's disease and mild cognitive impairment

Tanigawa T, Takechi H, Arai H, Yamada M, Nishiguchi S, Aoyama T.

Geriatr Gerontol Int. 2014 Oct;14(4):758-62. doi: 10.1111/ggi.12159. Epub 2014 Mar 20.

Verbal repetition in primary progressive aphasia and Alzheimer's disease

Leyton CE, Savage S, Irish M, Schubert S, Piguet O, Ballard KJ, Hodges JR.

J Alzheimers Dis. 2014;41(2):575-85. doi: 10.3233/JAD-132468.

Increased plasma TACE activity in subjects with mild cognitive impairment and patients with Alzheimer's disease

Sun Q, Hampel H, Blennow K, Lista S, Levey A, Tang B, Li R, Shen Y.

J Alzheimers Dis. 2014;41(3):877-86. doi: 10.3233/JAD-140177.

Managing patients on antipsychotics: your domain, too

Moore R 2nd, DeJoseph D, Simmons BB.

J Fam Pract. 2014 Mar;63(3):142-9.

How are we going to live with Alzheimer's disease?

Karlawish J.

Health Aff (Millwood). 2014 Apr;33(4):541-6. doi: 10.1377/hlthaff.2014.0089.

Alzheimer's disease in African Americans: risk factors and challenges for the future

Barnes LL, Bennett DA.

Health Aff (Millwood). 2014 Apr;33(4):580-6. doi: 10.1377/hlthaff.2013.1353.

Cognitive and neuroimaging profiles in mild cognitive impairment and Alzheimer's disease: data from the Spanish Multicenter Normative Studies (NEURONORMA Project)

Sánchez-Benavides G, Peña-Casanova J, Casals-Coll M, Gramunt N, Molinuevo JL, Gómez-Ansón B, Aguilar M, Robles A, Antúnez C, Martínez-Parra C, Frank-García A, Fernández-Martínez M, Blesa R; NEURONORMA Study Team.

J Alzheimers Dis. 2014;41(3):887-901. doi: 10.3233/JAD-132186.

Altered amplitude of low-frequency fluctuations in early and late mild cognitive impairment and Alzheimer's disease

Liang P, Xiang J, Liang H, Qi Z, Li K, Alzheimer's Disease NeuroImaging Initiative.

Curr Alzheimer Res. 2014 May;11(4):389-98. doi: 10.2174/1567205011666140331225335.

Association of rs6265 and rs2030324 polymorphisms in brain-derived neurotrophic factor gene with Alzheimer's disease: a meta-analysis

Lin Y, Cheng S, Xie Z, Zhang D.

PLoS One. 2014 Apr 14;9(4):e94961. doi: 10.1371/journal.pone.0094961. eCollection 2014.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias